GlassScriptPhysician profile
Joel W Simon
NPI 1861751950
$22,674.07
in general payments reported to CMS, 2019-2025
36 companies · $4,294 in 2025
The $4,294 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,433 · 2020: $178 · 2021: $1,506 · 2022: $3,970 · 2023: $1,539 · 2024: $4,753 · 2025: $4,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,615 · Travel and Lodging: $2,412 · Consulting Fee: $500 · Entertainment: $59.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,615.00 |
| Travel and Lodging | $2,412.19 |
| Consulting Fee | $500.00 |
| Entertainment | $59.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,794.03 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, Watchman Flx |
| Abbott Laboratories | $5,213.68 | 2019-2025 | Aveir, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $3,564.30 | 2019-2020 | |
| Biotronik INC. | $1,132.73 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Edora 8 Dr-T |
| Medtronic, INC. | $875.34 | 2021-2025 | Azure Xt Dr Mri Surescan, Mycarelink, Onyx Frontier |
| Atricure, INC. | $797.58 | 2022-2025 | Atriclip Laa Exclusion System |
| Biosense Webster, INC. | $776.37 | 2021-2025 | Carto 3, Na, Nuvision Ice Catheter |
| Pfizer INC. | $508.09 | 2022-2025 | |
| Aop Health US, LLC | $507.48 | 2025 | Rapiblyk |
| Vektor Medical INC. | $500.00 | 2024 | Vmap |
| Impulse Dynamics (USA) INC. | $298.40 | 2022-2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.79 | 2021-2024 | Lifevest |
| Amgen INC. | $140.07 | 2022-2024 | Repatha |
| Siemens Medical Solutions USA, INC. | $129.18 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Stereotaxis INC | $128.59 | 2021-2024 | Genesis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.57 | 2021-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $109.16 | 2022-2025 | Onpattro |
| Volta Medical INC | $106.38 | 2025 | Vx1 |
| E.R. Squibb & Sons, L.L.C. | $104.95 | 2022-2024 | Eliquis, Camzyos |
| Novo Nordisk INC | $102.35 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $91.76 | 2023-2024 | Brilinta, Andexxa, Wainua |
| Merck Sharp & Dohme LLC | $83.37 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $77.00 | 2022-2025 | |
| Cardiva Medical, INC. | $58.93 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Kiniksa Pharmaceuticals International, Plc | $42.34 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $38.43 | 2023-2025 | |
| Cvrx, INC. | $33.63 | 2022-2023 | Barostim Neo System |
| Zoll Respicardia, INC. | $21.52 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.53 | 2025 | Edarbi |
| Lilly USA, LLC | $18.00 | 2025 | Zepbound |
| Philips North America LLC | $17.23 | 2023 | |
| Sanofi-Aventis U.S. LLC | $16.11 | 2022 | |
| Terumo Medical Corporation | $15.72 | 2024 | Tr Band, Angio-Seal |
| Amryt Pharma Holdings LTD | $15.68 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $15.66 | 2023 | Arcalyst |
| Cardiovascular Systems INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.